Camposol Holding PLC: Key Q2 and H1 2025 Financial Insights

Camposol Holding PLC: Key Financial Insights for 2025
Today, Camposol Holding PLC, a leading multinational dedicated to providing fresh and healthy food, shared its preliminary financial results for the second quarter that ended mid-year. The report was crafted in alignment with International Financial Reporting Standards (IFRS), although these numbers may be subject to revisions as the audited results become available.
First Half of 2025: A Snapshot
This half of the year reflected remarkable growth across various metrics. The volume sold reached 55,162 MT, which is an impressive 38% increase compared to the previous year. Furthermore, total sales soared to USD 222 million, demonstrating a 22% increase relative to 2024. EBITDA rose to USD 67 million, marking a 9% improvement compared to last year.
Net Earnings and Debt Ratio
However, net profit for the first half was reported at USD 16 million, which is a decline of 17% compared to the same period last year. Notably, Camposol maintained a strong Net Debt-to-EBITDA ratio of 2.59x, continuing a streak of four consecutive quarters below the critical threshold of 3.5x.
Highlights from the Second Quarter
In addition to robust financial figures, Camposol achieved several operational milestones during the second quarter:
Quality and Certification Achievements
Notably, the Chao plant secured an AA+ rating in the BRCGS audit. This level of recognition showcases the high standards Camposol maintains in food safety and quality. Furthermore, the organic certification for Camposol Fresh VB in the Netherlands has been successfully restored, highlighting the company's commitment to sustainability and quality assurance.
Commitment to Traceability
Demonstrating its dedication to operational integrity, Camposol was honored by BASC Peru, acknowledging 20 years of commitment to enhancing the traceability of its operations. This recognition marks the company's dedication to maintaining safety standards and operational excellence.
Laboratory Achievements
In a significant achievement, the Biotech Laboratory of Camposol crossed a milestone by delivering over one million plants, showcasing the innovation and growth inherent in its proprietary varieties.
Insights from the CEO
CEO Ricardo Naranjo voiced optimism about the financial results, stating, "The first half of 2025 confirmed the strength of our strategy and disciplined execution. With an EBITDA margin of 30%, we have demonstrated that our financial management is effective. Maintaining the Net Debt-to-EBITDA ratio at 2.59x emphasizes solid fiscal health, benefiting both the company and its stakeholders.”
Review of Product Segments
An in-depth analysis of product segments reveals that blueberry production exploded by 50.2%, reaching 27.2 thousand MT, with sales increasing to USD 162.2 million. The targeted pruning strategy emphasized production earlier in the year, leading to enhanced operational efficiency.
Strong Returns from Mangoes and Grapes
This year’s mango segment also performed solidly, achieving a gross profit margin of 36.5% due to excellent field execution, despite a more typical market condition compared to last year’s high prices. Additionally, the grape segment saw a remarkable resurgence with volumes five times higher than the prior year’s first half, recording a staggering 603% rise in revenue.
Financial Management and Returns
Camposol's continued discipline in financial management was evident as short-term debts made up less than 25% of the total, ensuring a resilient capital structure. The company also rewarded shareholders with USD 28.5 million in dividends while investing in key growth initiatives, signaling a proactive approach to future challenges.
Join Us for Upcoming Insights
To engage thoroughly with the company’s financial trajectory, stakeholders are encouraged to participate in the scheduled conference call to discuss these results. Details for registration have been provided in communications to ensure broad participation.
Frequently Asked Questions
What were Camposol’s total sales for the first half of 2025?
Camposol reported total sales of USD 222 million for the first half of 2025.
How does Camposol's Net Debt-to-EBITDA ratio compare to previous quarters?
The Net Debt-to-EBITDA ratio is maintained at 2.59x, below the 3.5x threshold for four consecutive quarters.
What significant certifications did Camposol achieve recently?
Camposol secured an AA+ rating in the BRCGS audit and reinstated its organic certification for Camposol Fresh VB in the Netherlands.
What improvements were noted in the blueberry segment?
Blueberry volumes grew by 50.2% year-over-year, demonstrating strong operational strategy and enhanced efficiency.
Who should potential investors contact for more information?
For more information, potential investors can contact Jossue Yesquen Lihim via email at jyesquen@camposol.com.
About The Author
Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.